Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125086142 | 12508614 | 2 | F | 2006 | 20160705 | 20160629 | 20160712 | EXP | BR-ELI_LILLY_AND_COMPANY-BR201605001432 | ELI LILLY AND CO | 0.00 | F | Y | 81.00000 | KG | 20160712 | CN | BR | BR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125086142 | 12508614 | 1 | PS | HUMULIN N | INSULIN HUMAN | 1 | Subcutaneous | UNK UNK, EACH MORNING | N | U | 18780 | INJECTION | QD | ||||||
125086142 | 12508614 | 2 | SS | HUMULIN N | INSULIN HUMAN | 1 | Subcutaneous | 8 IU, QD | N | U | 18780 | 8 | IU | INJECTION | QD | ||||
125086142 | 12508614 | 3 | SS | HUMULIN N | INSULIN HUMAN | 1 | Subcutaneous | 8 IU, EACH EVENING | N | U | 18780 | 8 | IU | INJECTION | QD | ||||
125086142 | 12508614 | 4 | SS | HUMULIN R | INSULIN HUMAN | 1 | Unknown | 8 IU, EACH MORNING | N | U | 0 | 8 | IU | QD | |||||
125086142 | 12508614 | 5 | SS | HUMULIN R | INSULIN HUMAN | 1 | Unknown | 8 IU, EACH EVENING | N | U | 0 | 8 | IU | QD | |||||
125086142 | 12508614 | 6 | C | ATENOLOL. | ATENOLOL | 1 | Unknown | 100 MG, QD | 0 | 100 | MG | QD | |||||||
125086142 | 12508614 | 7 | C | ENALAPRIL | ENALAPRIL | 1 | Unknown | 5 MG, BID | 0 | 5 | MG | BID | |||||||
125086142 | 12508614 | 8 | C | AAS | ASPIRIN | 1 | 0 | ||||||||||||
125086142 | 12508614 | 9 | C | MONOCORDIL | ISOSORBIDE MONONITRATE | 1 | Unknown | 20 MG, TID | 0 | 20 | MG | TID | |||||||
125086142 | 12508614 | 10 | C | DILTIAZEM. | DILTIAZEM | 1 | Unknown | 30 MG, BID | 0 | 30 | MG | BID | |||||||
125086142 | 12508614 | 11 | C | DILTIAZEM. | DILTIAZEM | 1 | 0 | ||||||||||||
125086142 | 12508614 | 12 | C | SINVASTATINA | SIMVASTATIN | 1 | 40 MG, UNK | 0 | 40 | MG | |||||||||
125086142 | 12508614 | 13 | C | DIAZEPAM. | DIAZEPAM | 1 | 0 | ||||||||||||
125086142 | 12508614 | 14 | C | OMEPRAZOL /00661201/ | OMEPRAZOLE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125086142 | 12508614 | 1 | Type 1 diabetes mellitus |
125086142 | 12508614 | 4 | Type 1 diabetes mellitus |
125086142 | 12508614 | 6 | Blood pressure abnormal |
125086142 | 12508614 | 7 | Diuretic therapy |
125086142 | 12508614 | 9 | Vasodilatation |
125086142 | 12508614 | 10 | Mitral valve disease |
125086142 | 12508614 | 11 | Palpitations |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125086142 | 12508614 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125086142 | 12508614 | Arteriosclerosis | |
125086142 | 12508614 | Chest pain | |
125086142 | 12508614 | Complication associated with device | |
125086142 | 12508614 | Drug effect delayed | |
125086142 | 12508614 | Dysgeusia | |
125086142 | 12508614 | Dyspnoea | |
125086142 | 12508614 | Hyperglycaemia | |
125086142 | 12508614 | Hypoglycaemia | |
125086142 | 12508614 | Injection site bruising | |
125086142 | 12508614 | Injection site pain | |
125086142 | 12508614 | Injection site swelling | |
125086142 | 12508614 | Injection site vesicles | |
125086142 | 12508614 | Myocardial infarction | |
125086142 | 12508614 | Underdose | |
125086142 | 12508614 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125086142 | 12508614 | 4 | 2012 | 2014 | 0 | |
125086142 | 12508614 | 5 | 2012 | 2014 | 0 |